EP4265300
COMPOSITION COMPRISING A 17 A-HYDROXYLASE/C17,20 LYASE (CYP17A1) INHIBITOR AND AN AKT INHIBITOR
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
1.10.2014EP published:
10.12.2025EP application number:
23175752.7
EPO information:
European Patent Register
Max expiry date:
30.9.2034Expiry date:
30.9.2026
Title in English:
COMPOSITION COMPRISING A 17 A-HYDROXYLASE/C17,20 LYASE (CYP17A1) INHIBITOR AND AN AKT INHIBITORLanguage of the patent:
English
Timeline
Today
1.10.2014EP application
10.12.2025EP Publication
30.9.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
CORNFELD, Mark J.Address:
Collegeville, 19426, US
Name:
KUMAR, RakeshAddress:
Collegeville, 19426, US
Name:
MORRIS, Shannon RenaeAddress:
Research Triangle, 27709, US
Priority
Number:
201361885049 PDate:
1.10.2013Country:
US
Number:
201461933379 PDate:
30.1.2014Country:
US
Classification
Categories:
A61K 31/4155, A61K 31/4375, A61K 31/58, A61K 45/06, A61P 35/00, A61P 35/04, A61P 43/00